OPRX
OptimizeRx Corp

1,124
Mkt Cap
$124.33M
Volume
83,917.00
52W High
$22.25
52W Low
$5.54
PE Ratio
25.59
OPRX Fundamentals
Price
$6.22
Prev Close
$6.67
Open
$6.50
50D MA
$10.26
Beta
1.61
Avg. Volume
457,450.42
EPS (Annual)
$0.2701
P/B
0.98
Rev/Employee
$848,286.82
$235.66
Loading...
Loading...
News
all
press releases
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $20.00 by Analysts at Lake Street Capital
Lake Street Capital reduced their price target on shares of OptimizeRx from $24.00 to $20.00 and set a "buy" rating for the company in a research report on Friday...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $18.00 by Analysts at Roth Mkm
Roth Mkm reduced their price objective on OptimizeRx from $32.00 to $18.00 and set a "buy" rating for the company in a research note on Friday...
MarketBeat·6d ago
News Placeholder
OptimizeRx Warns Of Volatility From 'Most Favored Nation' Pricing Uncertainty
OptimizeRx CEO warns of increased market volatility and uncertainty around MFN pricing. Lower 2026 forecasts due to cautious spending.read more...
Benzinga·6d ago
News Placeholder
B. Riley Financial Reaffirms Buy Rating for OptimizeRx (NASDAQ:OPRX)
B. Riley Financial reissued a "buy" rating and set a $11.00 target price (down from $28.00) on shares of OptimizeRx in a research report on Friday...
MarketBeat·6d ago
News Placeholder
Stephens Cuts OptimizeRx (NASDAQ:OPRX) Price Target to $10.00
Stephens dropped their price objective on OptimizeRx from $17.00 to $10.00 and set an "equal weight" rating on the stock in a report on Friday...
MarketBeat·6d ago
News Placeholder
OptimizeRx (NASDAQ:OPRX) Announces Quarterly Earnings Results
OptimizeRx (NASDAQ:OPRX - Get Free Report) announced its quarterly earnings data on Thursday. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.23 by...
MarketBeat·6d ago
News Placeholder
OptimizeRx Q4 Earnings Call Highlights
OptimizeRx (NASDAQ:OPRX) reported fourth-quarter and full-year fiscal 2025 results that management said exceeded both internal expectations and consensus estimates, driven by growth across...
MarketBeat·6d ago
News Placeholder
Stock Repurchase Plan Initiated by OptimizeRx (NASDAQ:OPRX) Board of Directors
OptimizeRx (NASDAQ:OPRX - Get Free Report) announced that its board has authorized a share repurchase plan on Thursday, March 5th, RTT News reports. The company plans to repurchase $10.00 million in...
MarketBeat·7d ago
News Placeholder
OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·7d ago
News Placeholder
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates
OptimizeRx (OPRX) delivered earnings and revenue surprises of +119.36% and +2.10%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·7d ago
<
1
2
...
>

Latest OPRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.